Evidence map›Paper›PMID 39681961›Full record

ReviewBMC global and public health2023

Early user perspectives on using computer-aided detection software for interpreting chest X-ray images to enhance access and quality of care for persons with tuberculosis.

Jacob Creswell, Luan Nguyen Quang Vo, Zhi Zhen Qin, Monde Muyoyeta, Marco Tovar, Emily Beth Wong, Shahriar Ahmed, Shibu Vijayan, Stephen John, Rabia Maniar and 4 more

Abstract readReview
In one paragraph

Review in BMC global and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jacob CreswellStop TB Partnership, Geneva, Switzerland. jacobc@stoptb.org.
Luan Nguyen Quang VoFriends for International TB Relief (FIT), Hanoi, Vietnam.
Zhi Zhen QinStop TB Partnership, Geneva, Switzerland.
Monde MuyoyetaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Marco TovarSocios En Salud Sucursal Peru, Lima, Peru.
Emily Beth WongAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Shahriar AhmedInternational Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Shibu VijayanPATH India, Mumbai, India.
Stephen JohnJanna Health Foundation, Yola, Nigeria.
Rabia ManiarInteractive Research and Development (IRD) Pakistan, Karachi, Pakistan.
Toufiq RahmanStop TB Partnership, Geneva, Switzerland.
Peter MacPhersonSchool of Health & Wellbeing, University of Glasgow, Glasgow, UK.
Sayera BanuInternational Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Andrew James CodlinFriends for International TB Relief (FIT), Hanoi, Vietnam.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite 30 years as a public health emergency, tuberculosis (TB) remains one of the world's deadliest diseases. Most deaths are among persons with TB who are not reached with diagnosis and treatment. Thus, timely screening and accurate detection of TB, particularly using sensitive tools such as chest radiography, is crucial for reducing the global burden of this disease. However, lack of qualified human resources represents a common limiting factor in many high TB-burden countries. Artificial intelligence (AI) has emerged as a powerful complement in many facets of life, including for the interpretation of chest X-ray images. However, while AI may serve as a viable alternative to human radiographers and radiologists, there is a high likelihood that those suffering from TB will not reap the benefits of this technological advance without appropriate, clinically effective use and cost-conscious deployment. The World Health Organization recommended the use of AI for TB screening in 2021, and early adopters of the technology have been using the technology in many ways. In this manuscript, we present a compilation of early user experiences from nine high TB-burden countries focused on practical considerations and best practices related to deployment, threshold and use case selection, and scale-up. While we offer technical and operational guidance on the use of AI for interpreting chest X-ray images for TB detection, our aim remains to maximize the benefit that programs, implementers, and ultimately TB-affected individuals can derive from this innovative technology.

Indexed as

AIImplementationScreeningThresholdsTuberculosisUse cases

Identifiers

PMID39681961
PMCPMC11622860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.